Flame Biosciences, Inc. — Form D
Flame Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-16. The offering totals $15.0M, of which $8.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-16
- Form: D
- Accession: 0001806233-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $8.5M
- Remaining: $6.5M
- Minimum investment: $25K
- Investors: 58
- Date of first sale: 2020-02-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-362910
Issuer
- Name: Flame Biosciences, Inc.
- CIK: 0001806233
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 555 MADISON AVENUE, SUITE 1201, NEW YORK, NY, 10022
- Phone: 908-432-5937
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Opler Tim | Director | New York, NY |
| George Avgerino | Executive Officer | New York, NY |
| Pamela Demain | Executive Officer | New York, NY |
| Leonid Gorelik | Executive Officer | New York, NY |
| David Barrett | Director | Waltham, MA |
| David Barrett | Executive Officer | Waltham, MA |
| Robert Stein | Director | Chanhassen, MN |
| TIM OPLER | Director | NEW YORK, NY |
| George Avgerinos | Executive Officer | New York, NY |
| Harlan Weisman | Director | RADNOR, PA |
| Harlan Weisman | Executive Officer | RADNOR, PA |
Other filings by this issuer (1)
More